Global Irreversible Electroporation (IRE) Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Irreversible Electroporation (IRE) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Irreversible Electroporation (IRE) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Irreversible Electroporation (IRE) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Irreversible Electroporation (IRE) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Irreversible Electroporation (IRE) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Irreversible Electroporation (IRE) include Acutus Medical, AngioDynamics, Kardium, Pulse Biosciences, Boston Scientific, Hangzhou Nuomao Medical Technology, Medtronic, Johnson & Johnson and Surgnova, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Irreversible Electroporation (IRE), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Irreversible Electroporation (IRE), also provides the sales of main regions and countries. Of the upcoming market potential for Irreversible Electroporation (IRE), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Irreversible Electroporation (IRE) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Irreversible Electroporation (IRE) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Irreversible Electroporation (IRE) sales, projected growth trends, production technology, application and end-user industry.

Irreversible Electroporation (IRE) Segment by Company

Acutus Medical
AngioDynamics
Kardium
Pulse Biosciences
Boston Scientific
Hangzhou Nuomao Medical Technology
Medtronic
Johnson & Johnson
Surgnova
Nortion
Shineyo Medical
Tianjin Intelligent Health Medical
Irreversible Electroporation (IRE) Segment by Type

Pulsed Field Ablation System
Steep Pulse Ablation System (NanoKnife)
Irreversible Electroporation (IRE) Segment by Application

Tumors
Cardiac Diseases
Irreversible Electroporation (IRE) Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Electroporation (IRE) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Irreversible Electroporation (IRE) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Electroporation (IRE).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Irreversible Electroporation (IRE) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Irreversible Electroporation (IRE) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irreversible Electroporation (IRE) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Irreversible Electroporation (IRE) Market by Type
1.2.1 Global Irreversible Electroporation (IRE) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pulsed Field Ablation System
1.2.3 Steep Pulse Ablation System (NanoKnife)
1.3 Irreversible Electroporation (IRE) Market by Application
1.3.1 Global Irreversible Electroporation (IRE) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Tumors
1.3.3 Cardiac Diseases
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Irreversible Electroporation (IRE) Market Dynamics
2.1 Irreversible Electroporation (IRE) Industry Trends
2.2 Irreversible Electroporation (IRE) Industry Drivers
2.3 Irreversible Electroporation (IRE) Industry Opportunities and Challenges
2.4 Irreversible Electroporation (IRE) Industry Restraints
3 Global Market Growth Prospects
3.1 Global Irreversible Electroporation (IRE) Revenue Estimates and Forecasts (2020-2031)
3.2 Global Irreversible Electroporation (IRE) Revenue by Region
3.2.1 Global Irreversible Electroporation (IRE) Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Irreversible Electroporation (IRE) Revenue by Region (2020-2025)
3.2.3 Global Irreversible Electroporation (IRE) Revenue by Region (2026-2031)
3.2.4 Global Irreversible Electroporation (IRE) Revenue Market Share by Region (2020-2031)
3.3 Global Irreversible Electroporation (IRE) Sales Estimates and Forecasts 2020-2031
3.4 Global Irreversible Electroporation (IRE) Sales by Region
3.4.1 Global Irreversible Electroporation (IRE) Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Irreversible Electroporation (IRE) Sales by Region (2020-2025)
3.4.3 Global Irreversible Electroporation (IRE) Sales by Region (2026-2031)
3.4.4 Global Irreversible Electroporation (IRE) Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Irreversible Electroporation (IRE) Revenue by Manufacturers
4.1.1 Global Irreversible Electroporation (IRE) Revenue by Manufacturers (2020-2025)
4.1.2 Global Irreversible Electroporation (IRE) Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Irreversible Electroporation (IRE) Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Irreversible Electroporation (IRE) Sales by Manufacturers
4.2.1 Global Irreversible Electroporation (IRE) Sales by Manufacturers (2020-2025)
4.2.2 Global Irreversible Electroporation (IRE) Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Irreversible Electroporation (IRE) Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Irreversible Electroporation (IRE) Sales Price by Manufacturers (2020-2025)
4.4 Global Irreversible Electroporation (IRE) Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Irreversible Electroporation (IRE) Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Irreversible Electroporation (IRE) Manufacturers, Product Type & Application
4.7 Global Irreversible Electroporation (IRE) Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Irreversible Electroporation (IRE) Market CR5 and HHI
4.8.2 2024 Irreversible Electroporation (IRE) Tier 1, Tier 2, and Tier 3
5 Irreversible Electroporation (IRE) Market by Type
5.1 Global Irreversible Electroporation (IRE) Revenue by Type
5.1.1 Global Irreversible Electroporation (IRE) Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Irreversible Electroporation (IRE) Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Irreversible Electroporation (IRE) Revenue Market Share by Type (2020-2031)
5.2 Global Irreversible Electroporation (IRE) Sales by Type
5.2.1 Global Irreversible Electroporation (IRE) Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Irreversible Electroporation (IRE) Sales by Type (2020-2031) & (Units)
5.2.3 Global Irreversible Electroporation (IRE) Sales Market Share by Type (2020-2031)
5.3 Global Irreversible Electroporation (IRE) Price by Type
6 Irreversible Electroporation (IRE) Market by Application
6.1 Global Irreversible Electroporation (IRE) Revenue by Application
6.1.1 Global Irreversible Electroporation (IRE) Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Irreversible Electroporation (IRE) Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Irreversible Electroporation (IRE) Revenue Market Share by Application (2020-2031)
6.2 Global Irreversible Electroporation (IRE) Sales by Application
6.2.1 Global Irreversible Electroporation (IRE) Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Irreversible Electroporation (IRE) Sales by Application (2020-2031) & (Units)
6.2.3 Global Irreversible Electroporation (IRE) Sales Market Share by Application (2020-2031)
6.3 Global Irreversible Electroporation (IRE) Price by Application
7 Company Profiles
7.1 Acutus Medical
7.1.1 Acutus Medical Comapny Information
7.1.2 Acutus Medical Business Overview
7.1.3 Acutus Medical Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Acutus Medical Irreversible Electroporation (IRE) Product Portfolio
7.1.5 Acutus Medical Recent Developments
7.2 AngioDynamics
7.2.1 AngioDynamics Comapny Information
7.2.2 AngioDynamics Business Overview
7.2.3 AngioDynamics Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 AngioDynamics Irreversible Electroporation (IRE) Product Portfolio
7.2.5 AngioDynamics Recent Developments
7.3 Kardium
7.3.1 Kardium Comapny Information
7.3.2 Kardium Business Overview
7.3.3 Kardium Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Kardium Irreversible Electroporation (IRE) Product Portfolio
7.3.5 Kardium Recent Developments
7.4 Pulse Biosciences
7.4.1 Pulse Biosciences Comapny Information
7.4.2 Pulse Biosciences Business Overview
7.4.3 Pulse Biosciences Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Pulse Biosciences Irreversible Electroporation (IRE) Product Portfolio
7.4.5 Pulse Biosciences Recent Developments
7.5 Boston Scientific
7.5.1 Boston Scientific Comapny Information
7.5.2 Boston Scientific Business Overview
7.5.3 Boston Scientific Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Boston Scientific Irreversible Electroporation (IRE) Product Portfolio
7.5.5 Boston Scientific Recent Developments
7.6 Hangzhou Nuomao Medical Technology
7.6.1 Hangzhou Nuomao Medical Technology Comapny Information
7.6.2 Hangzhou Nuomao Medical Technology Business Overview
7.6.3 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Product Portfolio
7.6.5 Hangzhou Nuomao Medical Technology Recent Developments
7.7 Medtronic
7.7.1 Medtronic Comapny Information
7.7.2 Medtronic Business Overview
7.7.3 Medtronic Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Medtronic Irreversible Electroporation (IRE) Product Portfolio
7.7.5 Medtronic Recent Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Comapny Information
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Johnson & Johnson Irreversible Electroporation (IRE) Product Portfolio
7.8.5 Johnson & Johnson Recent Developments
7.9 Surgnova
7.9.1 Surgnova Comapny Information
7.9.2 Surgnova Business Overview
7.9.3 Surgnova Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Surgnova Irreversible Electroporation (IRE) Product Portfolio
7.9.5 Surgnova Recent Developments
7.10 Nortion
7.10.1 Nortion Comapny Information
7.10.2 Nortion Business Overview
7.10.3 Nortion Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Nortion Irreversible Electroporation (IRE) Product Portfolio
7.10.5 Nortion Recent Developments
7.11 Shineyo Medical
7.11.1 Shineyo Medical Comapny Information
7.11.2 Shineyo Medical Business Overview
7.11.3 Shineyo Medical Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Shineyo Medical Irreversible Electroporation (IRE) Product Portfolio
7.11.5 Shineyo Medical Recent Developments
7.12 Tianjin Intelligent Health Medical
7.12.1 Tianjin Intelligent Health Medical Comapny Information
7.12.2 Tianjin Intelligent Health Medical Business Overview
7.12.3 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Product Portfolio
7.12.5 Tianjin Intelligent Health Medical Recent Developments
8 North America
8.1 North America Irreversible Electroporation (IRE) Market Size by Type
8.1.1 North America Irreversible Electroporation (IRE) Revenue by Type (2020-2031)
8.1.2 North America Irreversible Electroporation (IRE) Sales by Type (2020-2031)
8.1.3 North America Irreversible Electroporation (IRE) Price by Type (2020-2031)
8.2 North America Irreversible Electroporation (IRE) Market Size by Application
8.2.1 North America Irreversible Electroporation (IRE) Revenue by Application (2020-2031)
8.2.2 North America Irreversible Electroporation (IRE) Sales by Application (2020-2031)
8.2.3 North America Irreversible Electroporation (IRE) Price by Application (2020-2031)
8.3 North America Irreversible Electroporation (IRE) Market Size by Country
8.3.1 North America Irreversible Electroporation (IRE) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Irreversible Electroporation (IRE) Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Irreversible Electroporation (IRE) Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Irreversible Electroporation (IRE) Market Size by Type
9.1.1 Europe Irreversible Electroporation (IRE) Revenue by Type (2020-2031)
9.1.2 Europe Irreversible Electroporation (IRE) Sales by Type (2020-2031)
9.1.3 Europe Irreversible Electroporation (IRE) Price by Type (2020-2031)
9.2 Europe Irreversible Electroporation (IRE) Market Size by Application
9.2.1 Europe Irreversible Electroporation (IRE) Revenue by Application (2020-2031)
9.2.2 Europe Irreversible Electroporation (IRE) Sales by Application (2020-2031)
9.2.3 Europe Irreversible Electroporation (IRE) Price by Application (2020-2031)
9.3 Europe Irreversible Electroporation (IRE) Market Size by Country
9.3.1 Europe Irreversible Electroporation (IRE) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Irreversible Electroporation (IRE) Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Irreversible Electroporation (IRE) Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Irreversible Electroporation (IRE) Market Size by Type
10.1.1 China Irreversible Electroporation (IRE) Revenue by Type (2020-2031)
10.1.2 China Irreversible Electroporation (IRE) Sales by Type (2020-2031)
10.1.3 China Irreversible Electroporation (IRE) Price by Type (2020-2031)
10.2 China Irreversible Electroporation (IRE) Market Size by Application
10.2.1 China Irreversible Electroporation (IRE) Revenue by Application (2020-2031)
10.2.2 China Irreversible Electroporation (IRE) Sales by Application (2020-2031)
10.2.3 China Irreversible Electroporation (IRE) Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Irreversible Electroporation (IRE) Market Size by Type
11.1.1 Asia Irreversible Electroporation (IRE) Revenue by Type (2020-2031)
11.1.2 Asia Irreversible Electroporation (IRE) Sales by Type (2020-2031)
11.1.3 Asia Irreversible Electroporation (IRE) Price by Type (2020-2031)
11.2 Asia Irreversible Electroporation (IRE) Market Size by Application
11.2.1 Asia Irreversible Electroporation (IRE) Revenue by Application (2020-2031)
11.2.2 Asia Irreversible Electroporation (IRE) Sales by Application (2020-2031)
11.2.3 Asia Irreversible Electroporation (IRE) Price by Application (2020-2031)
11.3 Asia Irreversible Electroporation (IRE) Market Size by Country
11.3.1 Asia Irreversible Electroporation (IRE) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Irreversible Electroporation (IRE) Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Irreversible Electroporation (IRE) Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Irreversible Electroporation (IRE) Market Size by Type
12.1.1 SAMEA Irreversible Electroporation (IRE) Revenue by Type (2020-2031)
12.1.2 SAMEA Irreversible Electroporation (IRE) Sales by Type (2020-2031)
12.1.3 SAMEA Irreversible Electroporation (IRE) Price by Type (2020-2031)
12.2 SAMEA Irreversible Electroporation (IRE) Market Size by Application
12.2.1 SAMEA Irreversible Electroporation (IRE) Revenue by Application (2020-2031)
12.2.2 SAMEA Irreversible Electroporation (IRE) Sales by Application (2020-2031)
12.2.3 SAMEA Irreversible Electroporation (IRE) Price by Application (2020-2031)
12.3 SAMEA Irreversible Electroporation (IRE) Market Size by Country
12.3.1 SAMEA Irreversible Electroporation (IRE) Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Irreversible Electroporation (IRE) Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Irreversible Electroporation (IRE) Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Irreversible Electroporation (IRE) Value Chain Analysis
13.1.1 Irreversible Electroporation (IRE) Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Irreversible Electroporation (IRE) Production Mode & Process
13.2 Irreversible Electroporation (IRE) Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Irreversible Electroporation (IRE) Distributors
13.2.3 Irreversible Electroporation (IRE) Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings